Quantitative Determination and Toxicity Evaluation of Aristolochic Acid Analogues in Asarum heterotropoides F. Schmidt (Xixin) and Traditional Chinese Patent Medicines

Asarum (Xixin), which contains analogues of aristolochic acid (AA), is the only species of the genus Aristolochia included in the Chinese Pharmacopoeia 2020. However, the contents and nephrotoxic effects of AA analogs in Asarum (Xixin) and its formulations have not been clarified. An automatic, effe...

Full description

Saved in:
Bibliographic Details
Main Authors: Suyan Liu (Author), Zhong Xian (Author), Yong Zhao (Author), Lianmei Wang (Author), Jingzhuo Tian (Author), Chen Pan (Author), Jiayin Han (Author), Yushi Zhang (Author), Chunying Li (Author), Yan Yi (Author), Chenyue Liu (Author), Dunfang Wang (Author), Jing Meng (Author), Shasha Qin (Author), Fang Wang (Author), Aihua Liang (Author)
Format: Book
Published: Frontiers Media S.A., 2021-11-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_f48fb1af7c0f475e902cde2d7e3a20d9
042 |a dc 
100 1 0 |a Suyan Liu  |e author 
700 1 0 |a Zhong Xian  |e author 
700 1 0 |a Yong Zhao  |e author 
700 1 0 |a Lianmei Wang  |e author 
700 1 0 |a Jingzhuo Tian  |e author 
700 1 0 |a Chen Pan  |e author 
700 1 0 |a Jiayin Han  |e author 
700 1 0 |a Yushi Zhang  |e author 
700 1 0 |a Chunying Li  |e author 
700 1 0 |a Yan Yi  |e author 
700 1 0 |a Chenyue Liu  |e author 
700 1 0 |a Dunfang Wang  |e author 
700 1 0 |a Jing Meng  |e author 
700 1 0 |a Shasha Qin  |e author 
700 1 0 |a Fang Wang  |e author 
700 1 0 |a Aihua Liang  |e author 
245 0 0 |a Quantitative Determination and Toxicity Evaluation of Aristolochic Acid Analogues in Asarum heterotropoides F. Schmidt (Xixin) and Traditional Chinese Patent Medicines 
260 |b Frontiers Media S.A.,   |c 2021-11-01T00:00:00Z. 
500 |a 1663-9812 
500 |a 10.3389/fphar.2021.761593 
520 |a Asarum (Xixin), which contains analogues of aristolochic acid (AA), is the only species of the genus Aristolochia included in the Chinese Pharmacopoeia 2020. However, the contents and nephrotoxic effects of AA analogs in Asarum (Xixin) and its formulations have not been clarified. An automatic, effective solid phase extraction process and UPLC-MS/MS method were established for the pretreatment and quantitative detection of AA analogues in commercially available traditional Chinese patent medicines. The cytotoxicity and DNA damage induced by five analogues of AA were evaluated by CCK8 using human kidney cells (HK-2) and comet assays. HPLC was used to detect the analogues of AA in Asarum heterotropoides F. Schmidt (Xixin). The results showed that the contents of AA I, AA II, and AA IIIa were below the detection limit, while AA IVa and AL I presented relatively high contents of Asarum heterotropoides F. Schmidt (Xixin), within the range of 66.50-121.03 μg/g and 19.73-43.75 μg/g, respectively. The levels of AA analogues were in the nanogram-per-gram level in the main traditional Chinese patent medicines. AA I and AL I exhibited relatively high cytotoxicity at 48 h in CCK8 assays, while AA II, AA IIIa, and AA IVa showed weak cytotoxicity even at 800-1,000 μM. AA I induced significant pathological alterations and direct DNA damage at 40 mg/kg and 20 mg/kg, respectively. No distinct nephrotoxicity or hepatotoxicity was observed in mice treated with AA II, AA IIIa, AA IVa, or AL I at 40 mg/kg in this study. Consumption of Asarum heterotropoides F. Schmidt (Xixin) with controlled doses and periods is relatively safe as the contents of AA analogues in Asarum heterotropoides F. Schmidt (Xixin) and its formulations were far below those causing acute toxicity in this study. But, the long-term toxicity of Asarum heterotropoides F. Schmidt (Xixin) still needs further study. 
546 |a EN 
690 |a Asarum heterotropoides F. Schmidt 
690 |a aristolochic acid analogues 
690 |a content 
690 |a toxicity 
690 |a safety 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Frontiers in Pharmacology, Vol 12 (2021) 
787 0 |n https://www.frontiersin.org/articles/10.3389/fphar.2021.761593/full 
787 0 |n https://doaj.org/toc/1663-9812 
856 4 1 |u https://doaj.org/article/f48fb1af7c0f475e902cde2d7e3a20d9  |z Connect to this object online.